[Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide].
D001786:Blood Glucose / Q000032:analysis; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects*; D011863:Radioimmunoassay; D013450:Sulfones / Q000494:pharmacology*; D013729:Terpenes / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology*; D014508:Urea / Q000494:pharmacology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D013450:Sulfones; D013729:Terpenes; D014508:Urea; D014044:Tolbutamide
Vergleichende Untersuchungen zur betazytotropen Wirkung von Glibornuride, einem neuen Sulfonylharnstoffderivat, und Tolbutamid.